News NHS drug deal could fund vital cystic fibrosis research - Ve... Vertex wants long-term funding for CF research
News Call for new restrictions on UK vaccine prices Proposals also include fresh attack on drug prices
News Eisai disappointed after NICE rejects earlier use for breast... NICE says no to Halaven in second line breast cancer
News Vertex negotiating with NHS England on cystic fibrosis drug ... Vertex is trying reach a deal with NHS England to give patients access to all its approved cystic fibrosis (CF) drugs - and hopes it could also fund further drugs in the pipeline.
News NICE recommends funding for three thyroid cancer drugs Eisai's drug finally funded after two year delay
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
